Pamela Stephenson
Corporate Officer/Principal at DISC MEDICINE, INC.
Net worth: 1 M $ as of 2024-05-30
Pamela Stephenson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 2024-02-25 | - |
Career history of Pamela Stephenson
Former positions of Pamela Stephenson
| Companies | Position | Start | End |
|---|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Director/Board Member | 2019-02-18 | 2023-10-09 |
| Independent Dir/Board Member | 2019-02-18 | 2023-10-09 | |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2008-06-30 | 2019-02-28 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 2019-03-24 | - |
Training of Pamela Stephenson
| Brown University | Undergraduate Degree |
| Boston University School of Public Health | Graduate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| DISC MEDICINE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Pamela Stephenson
- Experience
